Effect of brefeldin A on membrane localization of MUC1 mucin and adhesive properties of cancer cells

Neoplasma

Volumn 55, Issue 4, 2008, Pages 305-311

  Porowska, H ^a   Paszkiewicz Gadek, A ^a   Lemancewicz, D ^a   Bielawski, T ^a   Wolczynski S ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Brefeldin A; Cancer cell lines; Cell adhesion; Integrins; MUC1

Indexed keywords

BREFELDIN A; COLLAGEN TYPE 1; MUCIN 1; VERY LATE ACTIVATION ANTIGEN 2; CA 15-3 ANTIGEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL SURFACE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ENDOMETRIUM CANCER; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; BREAST TUMOR; CELL MEMBRANE; DRUG EFFECT; ENDOMETRIUM TUMOR; FEMALE; METABOLISM; TUMOR CELL LINE;

BREAST NEOPLASMS; BREFELDIN A; CA-15-3 ANTIGEN; CELL ADHESION; CELL LINE, TUMOR; CELL MEMBRANE; COLLAGEN TYPE I; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INTEGRIN ALPHA2BETA1;

EID: 49949117295     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. GENDLER SJ. MUC1, The Renaissance molecule. J Mammary Gland Biol Neoplasia 2001; 6: 339-353.
2. HILKENS J, BUIJS F, HILGERS J et al. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors. Int J Cancer 1984; 34:197-206.
3. YIN L, LI Y, REN J et al. Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. J Biol Chem 2003; 278: 35458-35464.
4. KIM YJ, VARKI A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconjugate J 1997; 14: 569-576.
5. LEHLE L, TANNER W. The specific site of tunicamycin inhibitor of dolichol-bound N-acetylglucosamine derivatives. FEBS Lett 1976; 71: 167-170.
6. HO JJ, JAITUNI RS, CRAWLEY SC et al. N-glycosylation is required for the surface localization of MUC17 mucin. Int J Oncol 2003; 23: 585-592.
7. HENNEBICQ-REIG S, LESUFFLEUR T, CAPON C et al. Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion. Biochem J 1998; 334: 283-295.
8. HUET G, KIM I, DeBOLOS C et al. Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell population. J Cell Sci 1995; 108: 1275-1285.
9. FUJIWARA T, ODA K, YOLOTA S et al. Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J Biol Chem 1988; 263: 18545-18552.
10. KLAUSNER RD, DONALDSON JG, LIPPINCOTTSCHWARTZ J.: Brefeldin A - Insights into the control of membrane traffic and organelle structure. J Cell Biol 1992; 116: 1071-1080.
11. LIPPINCOTT-SCHWARTZ J, YUAN LC, BONIFACINO JS et al. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 1989; 56: 801-813.
12. LIPPINCOTT-SCHWARTZ J, YUAN L, TIPPER C et al. Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 1991; 67: 601-616.
13. RIPLEY CR, FANT J, BIENKOWSKI RS. Brefeldin A inhibits degradation as well as production and secretion of collagen in human lung fibroblasts. J Biol Chem 1993; 268: 3677-3682. (Pubitemid 23071013)
14. PASZKIEWICZ-GADEK A, POROWSKA H, LEMANCEWICZ D et al. The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines. Int J Mol Med 2006; 17: 669-674.
15. POROWSKA H, PASZKIEWICZ-GADEK A, ANCHIM T et al. Inhibition of the O-glycan elongation limits MUC1 incorporation to cell membrane of human endometrial carcinoma cells. Int J Mol Med 2004; 13: 459-464.
16. STRINDHALL J, LUNDBLAD A, PAHLSSON P. Interferon- γ enhancement of E-selectin expression on endothelial cells is inhibited by monensin. Scand J Immunol 1997; 46: 338-343. (Pubitemid 27431854)
17. DUFOUR S, BEAUVAIS-JOUNEAU A, DELOUVEE A, THIERY JP. Differential function of N-cadherin and cadherin- 7 in the control of embryonic cell motility. J Cell Biol 1999; 146: 501-516.
18. MARCINKIEWICZ C, LOBB RR, MARCINKIEWICZ MM et al. Isolation and characterization of EMS16, a C-lectin type protein from Echis multisquamatus venom, a potent and selective inhibitor of the alpha2beta1 integrin. Biochemistry 2000; 39: 9859-9867.
19. HOLLINGSWORTH MA, SWANSON BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004; 4: 45-60.
20. HILKENS J, BUIJS F. Biosynthesis of MAM-6, an epithelial sialomucin. Evidence for involvement of a rare proteolytic cleavage step in the endoplasmic reticulum. J Biol Chem 1988; 263: 4215-4222.
21. PARRY S, SILVERMAN HS, McDERMOTT, WILLIS A et al. Identification of MUC1 proteolytic cleavage sites in vivo. Biochem Biophys Res Commun 2001; 283: 715-720.
22. LITVINOV SV, HILKENS J. The epithelial sialomucin, episialin, is sialylated during recycling. J Biol Chem 1993; 268: 21364-21371. (Pubitemid 23292329)
23. NUCHTERN JG, BUNIFACINO JS, BADDISON WE et al. Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation. Nature 1989; 339: 223-226.
24. HUDSON TH, GRILLO FG. Brefeldin A enhancement of ricin A-chain immunotoxins and blockade of intact ricin, modeccin and abrin. J Biol Chem 1991; 266: 18586-18592.
25. YOSHIDA T, CHEN C, ZHANG M et al. Disruption of the Golgi apparatus by brefeldin A inhibits the cytotoxicity of ricin, modeccin and Pseudomonas toxin. Exp Cell Res 1991; 192: 389-395.
26. SPIRO RC, FREEZE HH, SAMPATH D et al. Uncoupling of chondroitin sulfate glycosaminoglycan synthesis by brefeldin A. J Cell Biol 1991; 115: 1463-1473.
27. WESSELING J, van der VALK SW, HILKENS J. A mechanism for inhibition of E-cadherin-mediated cellcell adhesion by the membrane-associated mucin episialin/ MUC1. Mol Biol Cell 1996; 7: 565-577.
28. WESSELING J, van der VALK SW, VOS HL et al. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995; 129: 255-265.
29. ZHANG K, BAECKSTROM D, BREVINGE H et al. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells. J Cell Biochem 1996; 60: 538-549.
30. HYNES RD: Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992; 69: 11-25.
31. LUNDSTROM A, HOLMBOM J, LINDQVIST C et al. The role of α2β1 and α3β1 integrin receptors in the initial anchoring of MDA-MB-231 human breast cancer cells to cortical bone matrix. Biochem Biophys Res Commun 1998; 250: 735-740.
32. FARQUHAR MG, PALADE GE. The Golgi apparatus: 100 years of progress and controversy. Trends Biol Cell 1998; 8: 2-10.
33. DOMS RW, RUSS G, YEWDELL JW. Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum. J Cell Biol 1989; 109: 61-72.
34. BALFOUR JA, McTAVISH D. Acarbose, an update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 1993; 46: 1025-1054. (Pubitemid 24016644)
35. GOSS PE, BAPTISTE J, FERNANDES B et al. A phase I study of swainsonine in patients with advanced malignancies. Cancer Res 1994; 54: 1450-1457. (Pubitemid 24106405)
36. TAYLOR DL, SUNKARA PS, LIU PS et al. 6-O-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs. AIDS 1991; 5: 693-698.